Dashboard
Manage Tickers

PGNYProgyny, Inc.

Nasdaq progyny.com


$ 32.04 $ -0.46 (-1.42 %)    

Friday, 26-Apr-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 32.04
$ 32.48
$ 0.00 x 0
$ 0.00 x 0
$ 31.99 - $ 32.67
$ 29.44 - $ 44.95
583,458
na
3.23B
$ 1.33
$ 51.99
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 08-05-2022 06-30-2022 10-Q
8 05-06-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-08-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-14-2020 03-31-2020 10-Q
17 03-10-2020 12-31-2019 10-K
18 12-06-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

truist-securities-reiterates-buy-on-progyny-maintains-46-price-target
Truist Securities Reiterates Buy on Progyn...
04/17/2024 17:21:36

Truist Securities analyst Jailendra Singh reiterates Progyny (NASDAQ:PGNY) with a Buy and maintains $46 price target.

why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Bumble Shares Are Trading Lower By 12%...
02/28/2024 19:02:02

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

cantor-fitzgerald-reiterates-overweight-on-progyny-maintains-48-price-target
Cantor Fitzgerald Reiterates Overweight on...
02/28/2024 16:14:36

Cantor Fitzgerald analyst Sarah James reiterates Progyny (NASDAQ:PGNY) with a Overweight and maintains $48 price target.

truist-securities-maintains-buy-on-progyny-lowers-price-target-to-46
Truist Securities Maintains Buy on Progyny...
02/28/2024 15:21:09

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $47 to...

keybanc-maintains-overweight-on-progyny-lowers-price-target-to-43
Keybanc Maintains Overweight on Progyny, L...
02/28/2024 10:09:42

Keybanc maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $45 to $43.

progyny-expects-q1-revenue-of-285m-292m-est-31264m-adjusted-eps-of-033-035-est-018
Progyny Expects Q1 Revenue Of $285M-$292M ...
02/27/2024 22:31:36

progyny-expects-2024-revenue-of-1285b-1315b-est-1311b-adjusted-eps-of-154-159-est-070
Progyny Expects 2024 Revenue Of $1.285B-$1...
02/27/2024 22:30:04

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
02/27/2024 21:31:08

progyny-q4-earnings-insights
Progyny: Q4 Earnings Insights
02/27/2024 21:15:10

progyny-q4-2023-gaap-eps-013-beats-010-estimate-sales-26994m-miss-27366m-estimate
Progyny Q4 2023 GAAP EPS $0.13 Beats $0.10...
02/27/2024 21:14:04

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.10 by 30 p...

earnings-scheduled-for-february-27-2024
Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

leerink-partners-initiates-coverage-on-progyny-with-outperform-rating-announces-price-target-of-49
Leerink Partners Initiates Coverage On Pro...
02/26/2024 14:15:29

Leerink Partners analyst Michael Cherny initiates coverage on Progyny (NASDAQ:PGNY) with a Outperform rating and announces P...

Core News & Articles
Presidential Candidate Donald Trump Says H...
02/23/2024 19:27:30

- Reuters

affordable-care-act-enrollment-highest-since-inception-obamacare-enrollment-witnesses-31-jump-in-2024
Affordable Care Act Enrollment Highest Sin...
01/25/2024 14:44:56

Historic milestone in healthcare: 21.3M Americans enroll in Obamacare, a 31% increase from last year. Act now, open enrollment ...

truist-securities-maintains-buy-on-progyny-lowers-price-target-to-47
Truist Securities Maintains Buy on Progyny...
11/08/2023 15:21:57

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $52 to...

analyst-ratings-for-progyny
Analyst Ratings for Progyny
11/08/2023 13:00:18

keybanc-maintains-overweight-on-progyny-lowers-price-target-to-45
Keybanc Maintains Overweight on Progyny, L...
11/08/2023 12:45:14

Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $50 to $45.

progyny-sees-q4-2023-revenue-2683m-276m-vs-27423m-est
Progyny Sees Q4 2023 Revenue $268.3M-$276M...
11/07/2023 21:42:28

Fourth Quarter of 2023 Outlook:Revenue is projected to be $268.3 million to $276.3 million, reflecting growth of 25% to 29%Net ...

progyny-sees-fy23-revenue-1087b-1095b-vs-108b-est
Progyny Sees FY23 Revenue $1.087B-$1.095B ...
11/07/2023 21:41:29

The Company is providing the following financial guidance for both the full year and three-month period ending December 31, 202...

progyny-q3-2023-eps-016-beats-012-estimate-revenue-280891m-beats-271189m-estimate
Progyny Q3 2023 EPS $0.16 Beats $0.12 Esti...
11/07/2023 21:39:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION